Although the clinical significance of these post‐translational modification sites remains to be determined, the current analyses do not rule out the possibility that the significantly decreased level of HMGB1 phosphorylation of S35 is a by‐product of a functionally significant dysregulated signal in tumour cells. Here, HMGB1 is linked to neoplasm.